Related Experiment Video
Updated: Sep 26, 2025

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus
Published on: August 25, 2017
Diagnosis and Treatment of Kaposi's Sarcoma
1Gastrointestinal Malignancies, University of Alabama-Birmingham, Division of Hematology-Oncology, Birmingham, AL.
Abstract:
Kaposi's sarcoma is the most common tumor associated with human immunodeficiency virus infection and is found in homosexual and bisexual men, injection drug users, and hemophiliacs. Its incidence has declined over the past 20 years, but it is not yet curable. Evaluation, biopsy, workup, and staging are essential to providing proper treatment. Immune system impairment is the single most important predictor of survival.
Insights
Kaposi's sarcoma, a common tumor in people with human immunodeficiency virus, requires evaluation, biopsy, and staging for treatment. Immune system health is the key factor influencing patient survival rates.
Area of Science:
- Oncology
- Infectious Diseases
- Immunology
Background:
- Kaposi's sarcoma is the most frequent tumor in individuals with human immunodeficiency virus (HIV).
- It disproportionately affects specific populations including homosexual and bisexual men, injection drug users, and hemophiliacs.
- Despite a decline in incidence over two decades, Kaposi's sarcoma remains incurable.
Purpose of the Study:
- To outline the essential steps in evaluating and treating Kaposi's sarcoma.
- To highlight the critical prognostic factors for patients diagnosed with Kaposi's sarcoma.
- To underscore the importance of immune status in managing this HIV-associated malignancy.
Main Methods:
- Diagnostic evaluation including biopsy.
- Clinical staging workup.
- Assessment of immune system status.
Main Results:
- Kaposi's sarcoma diagnosis and staging are crucial for appropriate treatment planning.
- Immune system impairment is identified as the primary predictor of survival in Kaposi's sarcoma patients.
- Treatment strategies must consider the patient's overall health and immune function.
Conclusions:
- Comprehensive evaluation, including biopsy and staging, is fundamental for managing Kaposi's sarcoma.
- Maintaining and improving immune function is paramount for enhancing survival outcomes.
- Further research into curable treatments for Kaposi's sarcoma is warranted.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Nephrotic Syndrome II : Assessment and Medical Management
Chronic Kidney Disease III: Interprofessional Care
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

